Our data also showed CD73 as a poor prognostic marker in the immune and stroma high groups and independence from both immune and stromal groups in MVA, suggesting that a tumor microenvironment rich in immune and stromal cells might be contributing to CD73’s prognostic role. The gene discussed is NT5E; the disease is neoplasm.